Dario PALMIERI | Research Scientist | The Ohio State University, OH | OSU | Department of Molecular Virology, Immunology and Medical Genetics | Research profile
Pelotonia | Dario Palmieri
CRISPR / Gene Editing Core
Koru Biopharma Develops Exciting New Therapy for Pancreatic Cancer | Rev1 Ventures
Technology-Driven Future of Cancer Research - Knowinnovation
REMBRANDT: A high-throughput barcoded sequencing approach for COVID-19 screening | bioRxiv
RANBP9 as potential therapeutic target in non-small cell lung cancer
REMBRANDT: A High-Throughput Barcoded Sequencing Approach for COVID-19 Screening.
Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality | PLOS ONE
Buckeye Bullet Racing | Columbus OH
CRISPR / Gene Editing Core
Dario Capozzoli Archivi | Notizie Audaci
A garland of retractions for the Ohio State Department of Chutzpah Cancer Biology and Genetics | Statistical Modeling, Causal Inference, and Social Science
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
RANBP9 as potential therapeutic target in non-small cell lung cancer
IJMS | Free Full-Text | Cancer-Derived Extracellular Vesicle-Associated MicroRNAs in Intercellular Communication: One Cell's Trash Is Another Cell's Treasure
Shared gene editing resources with Nationwide Children's Hospital | OSUCCC – James - YouTube
Dario PALMIERI | Research Scientist | The Ohio State University, OH | OSU | Department of Molecular Virology, Immunology and Medical Genetics | Research profile
Mass COVID-19 patient screening using UvsX and UvsY mediated DNA recombination and high throughput parallel sequencing | Scientific Reports
Retractions 3 and 4 appear for researcher facing criminal probe; OSU co-author won't face inquiry – Retraction Watch
Dario Palmieri, PhD | Ohio State cancer researcher
Dario Palmieri | Molecular, Cellular and Developmental Biology
